Sai Life Sciences commences commercial operation of 2nd phase in Bidar
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The company received one observation in the Form-483
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company received 1 (One) observation in the Form-483
The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold
The acquisition sets up the foundation for a central hub of GMP value-added services and greater access to new customers in the rapidly growing Biopharma market
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
Subscribe To Our Newsletter & Stay Updated